Cytarabine ocfosfate hard capsule
US5512298A · kind A · utility
5Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 1993 |
| Grant date | Apr 30, 1996 |
| Priority date | — |
| Expiry date | Mar 24, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1652
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to hard capsules of cytarabine ocfosfate which is useful as an anti-leukemia drug applicable to oral administration. By providing the cytarabine ocfosfate hard capsule comprising (1) cytarabine ocfosfate, (2) a high molecular compound functioning as a disintegrator and (3) an alkali, there can be provided pharmaceutical preparations having excellent disintegration property and stability. The cytarabine ocfosfate hard capsules are applicable to clinical use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.